Gerald Berry

Publication Details

  • The use of (99m)technetium-labeled MCP-1 to assess graft coronary artery disease in rat cardiac allografts.

    Kown MH, Jahncke CL, Lijkwan MA, Koransky ML, Mari C, Berry GJ, Blankenberg FG, Strauss HW, Robbins RC. J Heart Lung Transplant. 2002; 21 (9): 1009-15

    Monocyte chemoattractant protein-1 (MCP-1) is associated with the development of graft coronary artery disease (GCAD) following cardiac transplantation. This study assessed whether technetium 99m ((99m)Tc)-labeled MCP-1 binds its receptors in chronic cardiac transplants and thereby provides a potential modality to assess GCAD.

    PubMedID: 12231372

Stanford Medicine Resources:

Footer Links: